Title
Category
Credits
Event date
Cost
  • Free-to-Member
  • Perioperative and Consultative Medicine
  • 2.00 ABIM MOC Self Evaluation Points
  • 2.00 AMA PRA Category 1 Credit™
$95.00
Preoperative testing can provide valuable information to identify patients who are at high risk for perioperative complications and reduce perioperative morbidity and mortality; however, there is little benefit from routinely testing patients who are known to be at low risk. The objectives of preoperative testing are to identify patients who are at high risk for perioperative complications, assess the severity or stability of existing medical problems, and evaluate abnormal symptoms or signs detected during the preoperative assessment. This module discusses the common challenges and pitfalls of preoperative testing, describes how pretest probability influences the decision to order preoperative tests, and identifies appropriate indications for laboratory, radiologic, and other forms of preoperative test screening. The selection of appropriate screening tools to identify patients at high risk for specific perioperative complications and the use of post-test probability to select and interpret preoperative diagnostic testing is also examined.
  • Free-to-Member
  • Perioperative and Consultative Medicine
  • 2.00 ABIM MOC Self Evaluation Points
  • 2.00 AMA PRA Category 1 Credit™
$95.00
Patients with cirrhosis who undergo surgery are at increased risk for complications. Perioperative morbidity and mortality vary depending on the severity of cirrhosis, type of surgery, and whether it is elective or emergent. Identification of cirrhosis and accurate assessment of severity can be challenging but is necessary for case selection, informed consent, and anticipation of potential complications. Inaccurate risk assessment can sometimes lead to inappropriate exclusion of patients with cirrhosis from receiving useful surgery, as well. For instance, reliance on the Child-Pugh score alone likely significantly over-estimates perioperative mortality in patients with cirrhosis undergoing most procedures. This module identifies updated tools for perioperative risk prediction, outlines the most important elements of preoperative evaluation and optimization, and assists in formulation of pre- and postoperative care plans for patients with cirrhosis. Though our main focus is on cirrhosis, we will also touch on some important topics related to other acute and chronic liver disease.
  • On Demand Bundles
$649.00
SHM Converge offers a comprehensive array of educational and networking opportunities designed specifically for the hospital medicine professional. Attendees can re-energize and focus their practice with the latest research, best practices and newest innovations in the field that can immediately be applied to improving patient care.
  • On Demand Bundles
$649.00
SHM Converge offers a comprehensive array of educational and networking opportunities designed specifically for the hospital medicine professional. Attendees can re-energize and focus their practice with the latest research, best practices and newest innovations in the field that can immediately be applied to improving patient care.Target AudienceHospitalists, physician leaders and practice administrators; hospital, health plan and medical group executives.
  • On Demand Bundles
  • 44.50 ABIM MOC Self Evaluation Points
  • 89.00 AMA PRA Category 1 Credit™
  • 89.00 Non-physician
$649.00
SHM Converge offers a comprehensive array of educational and networking opportunities designed specifically for the hospital medicine professional. These recording contain the best content from the live event, viewable at your convenience. Re-energize and focus your practice with the latest research, best practices, and newest innovations in the field that can immediately be applied to improving patient care.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis. In this fourth and final session in this series on heart failure, faculty will present opportunities, strategies and updates for heart failure care for hospitalists, including: 1. Hot off the press results including VICTORIAvii, GALACTICviii, AFFIRM-AHFix trials 2. Strategies to optimize inpatient care pathways including cardiology co-management This session was moderated by Dr. Jagriti Chadha, MD, MPH, FACP, FHM. Panelists include Dr. Suchita Shah Sata, MD, FACP, SFHM, and Dr. Alfred Burger, MD, MS, FACP, SFHM.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis. This is the third session in a four-part series, SHM Clinical Rapid Updates: Heart Failure. This session covers quality improvement focused approach for heart failure patient during hospitalization. Specific subtopics addressed in this session include: 1. Describe novel HF therapies that are potential QI targets including SGLT2 inhibitors alone and in combination w/ ANRI 2. Describe results of recent studies as potential QI targets including EMPRROR Reducediv and DAPA HFv 3. Discuss QI efforts in this area This panel was moderated by Dr. Jagriti Chadha, MD, FHM. Our panelists included Dr. Tresa McNeal, MD, FACP, SFHM, Interim Chair for the Department of Medicine at BSW Medical Center in Temple, Texas, and Dr. Dustin Smith, MD, SFHM, Associate Professor of Medicine at Emory University School of Medicine in Atlanta, Georgia.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis. This is the second session in a four-part series, SHM Clinical Rapid Updates: Heart Failure. This session covers heart failure care during hospitalization, and through transition of care. Specific subtopics addressed in this session include: 1. Preventing recurrent hospitalizations based on PARADIGM-HFii trial 2. Tools and strategies for optimal transitions from inpatient to outpatient 3. Potential roles for telemonitoring and cardio-MEMs This panel was moderated by Dr. Jagriti Chadha, MD, FHM. Our panelists included Dr. Tresa McNeal, MD, FACP, SFHM, Interim Chair for the Department of Medicine at BSW Medical Center in Temple, Texas, and Dr. Dustin Smith, MD, SFHM, Associate Professor of Medicine at Emory University School of Medicine in Atlanta, Georgia.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis. The four-part series, SHM Clinical Rapid Updates: Heart Failure, opens with this session outlining guideline-directed medical therapy in heart failure patients, focusing on the impact of care optimization provided by hospitalists. Specific subtopics addressed include: - the importance of rapid decongestion - the importance of initiation of GDMT - inpatient initiate and titration of ARNI This session is moderated by Joseph Sweigart, MD, FHM, SFHM. Our panelists include Ebrahim Barkoudah, MD, FACP, MPH, FHM, SFHM and Nurcan Ilksoy, MD, FACP, FHM.
  • Free-to-Member
  • Rapid Clinical Updates
$0.00
Participants may register in the entire series by registering for this parent course, or click on an individual session title to register for that select course.This series of activities was made possible in part by an educational grant from Novartis.SummaryRapid Clinical Updates is designed to reach Society of Hospital Medicine members and other hospitalists ’clinicians with the latest information on clinical updates and treatment when and where they need it most, with actionable education that will help clinicians improve case delivery

Pages